CG
BBNX

Caprock Group’s Beta Bionics BBNX Stock Holding History

Caprock Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Buy
18,847
+6,730
+56% +$99.5K ﹤0.01% 1055
2025
Q4 		$369K Buy
12,117
+1,769
+17% +$47.2K 0.01% 923
2025
Q3 		$195K Buy
+10,348
New +$182K ﹤0.01% 1072

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Caprock Group's BBNX Position: Q1 2026 in Review

Caprock Group increased its Beta Bionics (BBNX) stake by 56% in Q1 2026, buying an estimated $99.5K and bringing the position to 18,847 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Caprock Group first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $369K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Caprock Group held 18,847 shares of Beta Bionics worth $189K as of Q1 2026.
  • Caprock Group bought 6,730 Beta Bionics shares in Q1 2026, an estimated $99.5K.
  • Beta Bionics made up ﹤0.01% of Caprock Group's portfolio in Q1 2026, its #1055 holding.
  • Caprock Group first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • Caprock Group's Beta Bionics position peaked at $369K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.